{"id":17067,"date":"2022-11-02T15:55:13","date_gmt":"2022-11-02T14:55:13","guid":{"rendered":"https:\/\/www.joffeassocies.com\/medsenic-merges-with-bone-therapeutics\/"},"modified":"2026-09-28T16:11:44","modified_gmt":"2026-09-28T14:11:44","slug":"medsenic-merges-with-bone-therapeutics","status":"publish","type":"post","link":"https:\/\/www.joffeassocies.com\/en\/medsenic-merges-with-bone-therapeutics\/","title":{"rendered":"Medsenic merges with Bone Therapeutics"},"content":{"rendered":"

Link to the CF News article: Medsenic article<\/p>\n

 <\/p>\n

In order to launch phase 3 of its clinical trial into the treatment of chronic graft-versus-host disease using arsenic salts, the Strasbourg-based company Medsenic is merging with the Belgian firm Bone Therapeutics, a specialist in orthopaedic cell therapy, on 25 October 2022. Medsenic is now conducting its trials of arsenic-based drugs across the border in Belgium. <\/strong><\/p>\n

 <\/p>\n

 <\/p>\n

The closing follows the fulfilment of all previous conditions precedent and the approval of the transaction at the Bone Therapeutics shareholders\u2019 meeting (\u2018ESM\u2019), which took place on Monday 24 October 2022.<\/p>\n

The majority of Medsenic\u2019s shareholders sold 51 per cent of the share capital in exchange for shares in Bone Therapeutics, at an estimated valuation of 40 million euros.<\/p>\n

 <\/p>\n

Renamed BioSenic upon completion of the transaction, the company is now led by Medsenic\u2019s current chairman, Fran\u00e7ois Rieger, who has been appointed CEO, supported by V\u00e9ronique Pomi-Schneiter and Anne Leselbaum (Bone\u2019s medical director). Jean-Fran\u00e7ois Rax, the representative of Capital Grand Est, sits on the board of directors of Bone Therapeutics, which plans to acquire the remaining 49 per cent within thirty-six months.<\/p>\n

This merger will enable the company to become the scientific hub of the new entity, expanding its therapeutic portfolio beyond its current trials.<\/p>\n

 <\/p>\n

\u201cThis agreement with Bone Therapeutics highlights the value of Medsenic\u2019s highly complementary activities, offers our shareholders attractive and certain value, and brings together cutting-edge expertise and drug delivery platforms to accelerate growth and create new opportunities,\u201d said Fran\u00e7ois Rieger, Chairman and Chief Executive Officer of Medsenic.<\/p>\n

 <\/p>\n

\n

Lead lewyers:<\/p>\n

Christophe Joffe<\/a>, Oc\u00e9ane Christmann<\/a> and Fran\u00e7ois Gal\u00e9a<\/a><\/p>\n

 <\/p>\n

Parties involved in the transaction: <\/em><\/strong><\/p>\n

Target company: MEDSENIC<\/a><\/p>\n

Acquirer or investor: BIOSENIC<\/a>(EX BONE THERAPEUTICS)<\/a> , Jean St\u00e9phenne<\/a><\/p>\n

Seller: CAPITAL GRAND EST <\/a>, FA DIESE <\/a>, OUEST ANGELS CAPITAL <\/a>, BUSINESS ANGEL(S)<\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

Link to the CF News article: Medsenic article   In order to launch phase 3 of its clinical trial into the treatment of chronic graft-versus-host disease using arsenic salts, the Strasbourg-based company Medsenic is merging with the Belgian firm Bone Therapeutics, a specialist in orthopaedic cell therapy, on 25 October 2022. Medsenic is now conducting […]<\/p>\n","protected":false},"author":7,"featured_media":6534,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[12],"tags":[],"class_list":["post-17067","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-deals-en"],"acf":[],"yoast_head":"\nMedsenic merges and signs a deal with Bone Therapeutics<\/title>\n<meta name=\"description\" content=\"Medsenic is merging with Bone Therapeutics by selling 51 per cent of its share capital to them, based on an estimated valuation of 40 million euros.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.joffeassocies.com\/en\/medsenic-merges-with-bone-therapeutics\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Medsenic merges with Bone Therapeutics\" \/>\n<meta property=\"og:description\" content=\"Medsenic is merging with Bone Therapeutics by selling 51 per cent of its share capital to them, based on an estimated valuation of 40 million euros.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.joffeassocies.com\/en\/medsenic-merges-with-bone-therapeutics\/\" \/>\n<meta property=\"og:site_name\" content=\"Joffe & Associ\u00e9s\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-02T14:55:13+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-28T14:11:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.joffeassocies.com\/wp-content\/uploads\/2022\/11\/Med-Senic-novembre-2022-Site-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"348\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Valentin Poitou\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@JoffeAssocies\" \/>\n<meta name=\"twitter:site\" content=\"@JoffeAssocies\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Valentin Poitou\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.joffeassocies.com\/en\/medsenic-merges-with-bone-therapeutics\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.joffeassocies.com\/en\/medsenic-merges-with-bone-therapeutics\/\"},\"author\":{\"name\":\"Valentin Poitou\",\"@id\":\"https:\/\/www.joffeassocies.com\/#\/schema\/person\/e5592630e308ed4af81e692625cca7bc\"},\"headline\":\"Medsenic merges with Bone Therapeutics\",\"datePublished\":\"2022-11-02T14:55:13+00:00\",\"dateModified\":\"2026-09-28T14:11:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.joffeassocies.com\/en\/medsenic-merges-with-bone-therapeutics\/\"},\"wordCount\":309,\"image\":{\"@id\":\"https:\/\/www.joffeassocies.com\/en\/medsenic-merges-with-bone-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.joffeassocies.com\/wp-content\/uploads\/2022\/11\/Med-Senic-novembre-2022-Site-1.png\",\"articleSection\":[\"Deals\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.joffeassocies.com\/en\/medsenic-merges-with-bone-therapeutics\/\",\"url\":\"https:\/\/www.joffeassocies.com\/en\/medsenic-merges-with-bone-therapeutics\/\",\"name\":\"Medsenic merges and signs a deal with Bone Therapeutics\",\"isPartOf\":{\"@id\":\"https:\/\/www.joffeassocies.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.joffeassocies.com\/en\/medsenic-merges-with-bone-therapeutics\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.joffeassocies.com\/en\/medsenic-merges-with-bone-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.joffeassocies.com\/wp-content\/uploads\/2022\/11\/Med-Senic-novembre-2022-Site-1.png\",\"datePublished\":\"2022-11-02T14:55:13+00:00\",\"dateModified\":\"2026-09-28T14:11:44+00:00\",\"author\":{\"@id\":\"https:\/\/www.joffeassocies.com\/#\/schema\/person\/e5592630e308ed4af81e692625cca7bc\"},\"description\":\"Medsenic is merging with Bone Therapeutics by selling 51 per cent of its share capital to them, based on an estimated valuation of 40 million euros.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.joffeassocies.com\/en\/medsenic-merges-with-bone-therapeutics\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.joffeassocies.com\/en\/medsenic-merges-with-bone-therapeutics\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.joffeassocies.com\/en\/medsenic-merges-with-bone-therapeutics\/#primaryimage\",\"url\":\"https:\/\/www.joffeassocies.com\/wp-content\/uploads\/2022\/11\/Med-Senic-novembre-2022-Site-1.png\",\"contentUrl\":\"https:\/\/www.joffeassocies.com\/wp-content\/uploads\/2022\/11\/Med-Senic-novembre-2022-Site-1.png\",\"width\":800,\"height\":348,\"caption\":\"Med Senic fusionne avec Bone Therapeutics\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.joffeassocies.com\/en\/medsenic-merges-with-bone-therapeutics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.joffeassocies.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Medsenic merges with Bone Therapeutics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.joffeassocies.com\/#website\",\"url\":\"https:\/\/www.joffeassocies.com\/\",\"name\":\"Joffe & Associ\u00e9s\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.joffeassocies.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.joffeassocies.com\/#\/schema\/person\/e5592630e308ed4af81e692625cca7bc\",\"name\":\"Valentin Poitou\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.joffeassocies.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/747f77ed431582465814b5606637910b42405f7eb0063e215b2f68990a7befab?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/747f77ed431582465814b5606637910b42405f7eb0063e215b2f68990a7befab?s=96&d=mm&r=g\",\"caption\":\"Valentin Poitou\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Medsenic merges and signs a deal with Bone Therapeutics","description":"Medsenic is merging with Bone Therapeutics by selling 51 per cent of its share capital to them, based on an estimated valuation of 40 million euros.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.joffeassocies.com\/en\/medsenic-merges-with-bone-therapeutics\/","og_locale":"en_US","og_type":"article","og_title":"Medsenic merges with Bone Therapeutics","og_description":"Medsenic is merging with Bone Therapeutics by selling 51 per cent of its share capital to them, based on an estimated valuation of 40 million euros.","og_url":"https:\/\/www.joffeassocies.com\/en\/medsenic-merges-with-bone-therapeutics\/","og_site_name":"Joffe & Associ\u00e9s","article_published_time":"2022-11-02T14:55:13+00:00","article_modified_time":"2026-09-28T14:11:44+00:00","og_image":[{"width":800,"height":348,"url":"https:\/\/www.joffeassocies.com\/wp-content\/uploads\/2022\/11\/Med-Senic-novembre-2022-Site-1.png","type":"image\/png"}],"author":"Valentin Poitou","twitter_card":"summary_large_image","twitter_creator":"@JoffeAssocies","twitter_site":"@JoffeAssocies","twitter_misc":{"Written by":"Valentin Poitou","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.joffeassocies.com\/en\/medsenic-merges-with-bone-therapeutics\/#article","isPartOf":{"@id":"https:\/\/www.joffeassocies.com\/en\/medsenic-merges-with-bone-therapeutics\/"},"author":{"name":"Valentin Poitou","@id":"https:\/\/www.joffeassocies.com\/#\/schema\/person\/e5592630e308ed4af81e692625cca7bc"},"headline":"Medsenic merges with Bone Therapeutics","datePublished":"2022-11-02T14:55:13+00:00","dateModified":"2026-09-28T14:11:44+00:00","mainEntityOfPage":{"@id":"https:\/\/www.joffeassocies.com\/en\/medsenic-merges-with-bone-therapeutics\/"},"wordCount":309,"image":{"@id":"https:\/\/www.joffeassocies.com\/en\/medsenic-merges-with-bone-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/www.joffeassocies.com\/wp-content\/uploads\/2022\/11\/Med-Senic-novembre-2022-Site-1.png","articleSection":["Deals"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.joffeassocies.com\/en\/medsenic-merges-with-bone-therapeutics\/","url":"https:\/\/www.joffeassocies.com\/en\/medsenic-merges-with-bone-therapeutics\/","name":"Medsenic merges and signs a deal with Bone Therapeutics","isPartOf":{"@id":"https:\/\/www.joffeassocies.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.joffeassocies.com\/en\/medsenic-merges-with-bone-therapeutics\/#primaryimage"},"image":{"@id":"https:\/\/www.joffeassocies.com\/en\/medsenic-merges-with-bone-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/www.joffeassocies.com\/wp-content\/uploads\/2022\/11\/Med-Senic-novembre-2022-Site-1.png","datePublished":"2022-11-02T14:55:13+00:00","dateModified":"2026-09-28T14:11:44+00:00","author":{"@id":"https:\/\/www.joffeassocies.com\/#\/schema\/person\/e5592630e308ed4af81e692625cca7bc"},"description":"Medsenic is merging with Bone Therapeutics by selling 51 per cent of its share capital to them, based on an estimated valuation of 40 million euros.","breadcrumb":{"@id":"https:\/\/www.joffeassocies.com\/en\/medsenic-merges-with-bone-therapeutics\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.joffeassocies.com\/en\/medsenic-merges-with-bone-therapeutics\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.joffeassocies.com\/en\/medsenic-merges-with-bone-therapeutics\/#primaryimage","url":"https:\/\/www.joffeassocies.com\/wp-content\/uploads\/2022\/11\/Med-Senic-novembre-2022-Site-1.png","contentUrl":"https:\/\/www.joffeassocies.com\/wp-content\/uploads\/2022\/11\/Med-Senic-novembre-2022-Site-1.png","width":800,"height":348,"caption":"Med Senic fusionne avec Bone Therapeutics"},{"@type":"BreadcrumbList","@id":"https:\/\/www.joffeassocies.com\/en\/medsenic-merges-with-bone-therapeutics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.joffeassocies.com\/en\/"},{"@type":"ListItem","position":2,"name":"Medsenic merges with Bone Therapeutics"}]},{"@type":"WebSite","@id":"https:\/\/www.joffeassocies.com\/#website","url":"https:\/\/www.joffeassocies.com\/","name":"Joffe & Associ\u00e9s","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.joffeassocies.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.joffeassocies.com\/#\/schema\/person\/e5592630e308ed4af81e692625cca7bc","name":"Valentin Poitou","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.joffeassocies.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/747f77ed431582465814b5606637910b42405f7eb0063e215b2f68990a7befab?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/747f77ed431582465814b5606637910b42405f7eb0063e215b2f68990a7befab?s=96&d=mm&r=g","caption":"Valentin Poitou"}}]}},"_links":{"self":[{"href":"https:\/\/www.joffeassocies.com\/en\/wp-json\/wp\/v2\/posts\/17067","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.joffeassocies.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.joffeassocies.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.joffeassocies.com\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.joffeassocies.com\/en\/wp-json\/wp\/v2\/comments?post=17067"}],"version-history":[{"count":1,"href":"https:\/\/www.joffeassocies.com\/en\/wp-json\/wp\/v2\/posts\/17067\/revisions"}],"predecessor-version":[{"id":17074,"href":"https:\/\/www.joffeassocies.com\/en\/wp-json\/wp\/v2\/posts\/17067\/revisions\/17074"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.joffeassocies.com\/en\/wp-json\/wp\/v2\/media\/6534"}],"wp:attachment":[{"href":"https:\/\/www.joffeassocies.com\/en\/wp-json\/wp\/v2\/media?parent=17067"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.joffeassocies.com\/en\/wp-json\/wp\/v2\/categories?post=17067"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.joffeassocies.com\/en\/wp-json\/wp\/v2\/tags?post=17067"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}